Peter A. Csurhes
Herston, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.
Journal: Frontiers in neurology
Published: January 13, 2021
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Journal: JCI insight
Published: October 15, 2020
Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 09, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Journal: JCI insight
Published: September 11, 2018
Erratum: Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
Journal: Clinical & translational immunology
Published: July 28, 2017
Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
Journal: Clinical & translational immunology
Published: September 21, 2016
Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome.
Journal: Journal of neuroimmunology
Published: January 13, 2015
The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis.
Journal: Journal of neuroimmunology
Published: December 20, 2014
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 21, 2014
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 05, 2014
Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.
Journal: Journal of neuroimmunology
Published: July 28, 2013
CD8+ T cells far predominate over CD4+ T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines.
Journal: Blood
Published: December 18, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026